Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Prepaid Assets of $1.2 million for Q1 2026, up 345.65% year-over-year from $276000.0 in Q1 2025, and down 87.72% quarter-over-quarter from $10.0 million in Q4 2025.
Analysis
Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Prepaid Assets for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 345.65% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 345.65% YoY), while the FY2025 annual figure was $10.0 million, up 869.51% from the prior year.
- Prepaid Assets fell to $1.2 million in Q1 2026 per OLMA's latest filing, from $10.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $10.0 million in Q4 2025 and bottomed at $129000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $2.0 million across 5 years, with a median of $1.2 million in 2026.
- Annual changes were most pronounced in 2023 — Prepaid Assets slumped 89.76% — and 2024, when it jumped 1200.84%.
- Olema Pharmaceuticals' Prepaid Assets stood at $129000.0 in 2022, then jumped by 860.47% to $1.2 million in 2023, then dropped by 16.63% to $1.0 million in 2024, then jumped by 869.51% to $10.0 million in 2025, then plunged by 87.72% to $1.2 million in 2026.
- Business Quant data shows OLMA's Prepaid Assets at $1.2 million in Q1 2026, $10.0 million in Q4 2025, and $577000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Olema Pharmaceuticals | 1.13 Bn | 1.13 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.81 Mn |
| Mar 31, 2026 | 7.88 Mn |
| Dec 31, 2025 | 10.02 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 5.81 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 4.48 Mn |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 3.44 Mn |
| Sep 30, 2021 | 2.33 Mn |